Results for tag: "Aneurysm Drug"

The Aneurysm Drug market is a subset of the Cardiovascular Drugs market, which focuses on the treatment of aneurysms. Aneurysms are bulges in the walls of arteries, which can lead to serious health complications if left untreated. Aneurysm drugs are used to reduce the risk of aneurysm rupture, and to treat aneurysms that have already ruptured. These drugs can be administered orally, intravenously, or through an injection. Commonly used aneurysm drugs include anticoagulants, antiplatelet agents, and vasodilators. The Aneurysm Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, Sanofi, Bristol-Myers Squibb, and GlaxoSmithKline. Other companies in the market include AstraZeneca, Novartis, Bayer, and Eli Lilly. Show Less Read more